Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.6290
+0.0290 (4.83%)
At close: Mar 13, 2026, 4:00 PM EDT
0.6298
+0.0008 (0.13%)
After-hours: Mar 13, 2026, 6:01 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $25.69 million as of March 13, 2026. Its market cap has decreased by -34.15% in one year.
Market Cap
25.69M
Enterprise Value
-33.48M
1-Year Change
-34.15%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $25.69M, a decrease of -95.56%. That is a compound annual growth rate of -47.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 25.68M | -10.16% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 26.16M |
| Passage Bio | 25.98M |
| Tevogen Bio Holdings | 25.83M |
| Neuphoria Therapeutics | 25.50M |
| Boundless Bio | 25.32M |
| Exicure | 25.11M |
| NanoViricides | 25.05M |
| Vistagen Therapeutics | 24.99M |